Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Thymus Neoplasms 1Small Cell Lung Carcinoma 1Resected Pancreatic Adenocarcinoma 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Meningioma 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma 1Carcinoid Tumor 1Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 6pembrolizumab 5toripalimab 2fludarabine 2Valproic Acid 2Valganciclovir 2Injections 2Cyclophosphamide 2Cisplatin 2130-nm albumin-bound paclitaxel 2tislelizumab 1spartalizumab 1sapropterin 1fosaprepitant 1fludarabine phosphate 1camrelizumab 1Surgical Procedures, Operative 1Specimen Handling 1SHR-1701 1Protons 1Proton Therapy 1Panobinostat 1Medicare Part B 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-2 1Floxuridine 1Everolimus 1Dexamethasone 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Nasopharyngeal Carcinoma × Proton Therapy × Clear all
NCT04870840 2024-10-29

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
3 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡